OTCPK:BOIRF (France)  
Boiron SA logo

Boiron SA

$ 43.37 +3.42 (+8.56%) 09:30 AM EST
P/E:
16.62
P/B:
1.56
Market Cap:
$ 817.32M
Enterprise V:
$ 538.61M
Volume:
109.00
Avg Vol (2M):
190.00
Also Trade In:
Volume:
109.00
Market Cap $:
817.32M
PE Ratio:
16.62
Avg Vol (2-Month):
190.00
Enterprise Value $:
538.61M
PB Ratio:
1.56
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Boiron is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company's products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.

Financials

BOIRF's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:BOIRF

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 571.159
EPS (TTM) ($) 3.213
Beta 0.23
Volatility % 26.14
14-Day RSI 31.66
14-Day ATR ($) 0.750075
20-Day SMA ($) 43.9905
12-1 Month Momentum % -10.17
52-Week Range ($) 39.95 - 52
Shares Outstanding (Mil) 17.38

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Boiron SA Filings

Document Form Filing Date
No Filing Data

Boiron SA Analysis

Share your research

Headlines

See More
No news.